George is a specialist in life sciences with a particular focus on bioinformatics and software. He has experience prosecuting cases in many countries with a particular focus on Europe, the UK, the US, Canada, and China. George has drafted applications relating to lipid nanoparticles, cultured meat, machine learning software, and crop simulation software. He also has experience in EPO opposition and appeal work relating to antibody technology and food technology. George has done work for a range of clients from software start-ups to large multinational pharmaceutical companies.
Before qualifying as a Patent Attorney in 2019, George studied Natural Sciences at the University of Cambridge. George’s final year research project explored Cucumber Mosaic Virus and its interactions with plant defence mechanisms and pathways.
Published articles
- June 2024
Scientist Live, A look at the implications of new GMO laws (link) - March 2024
Process Engineering , Patents Pending (link) - February 2024
EIP Updates, EPO Board of Appeal applies the G2/21 test for post-published evidence (link) - January 2024
EIP Updates, Bioinformatics or Techbio: Semantic musings from a patent perspective (link) - December 2023
EIP Updates, Report on EPO Patent Knowledge Week (link)
Education
-
2019 — 2020
Certificate in Intellectual Property Litigation, Queen Mary, University of London -
2014 — 2015
MSc Management of Intellectual Property, Queen Mary, University of London -
2010 — 2013
MA Hons Natural Sciences, University of Cambridge, Downing College
Career history
- 2024 — Present
Senior Associate, EIP - 2023 — 2024
Associate, EIP - 2022 — 2023
Associate, Mewburn Ellis - 2019 — 2022
Associate , Marks & Clerk - 2015 — 2019
Trainee Patent Attorney, Marks & Clerk
Specialisms
Digital
- Digital health
- Medical imaging
- Software
Dynamics
- Additive manufacturing
Elements
- Food & flavour ingredients
- Pharmaceuticals
HealthTech
- Additive manufacturing
- Digital health
- Medical devices
- Medical imaging
- Personalised healthcare
- Surgical tools and implants
Life
- Agritech
- Biologics
- Biotech
- Cell therapy
- Gene editing
- Immunotherapy
- Microbiome
- Pharmaceuticals